{"name":"Michael Rippee","slug":"michael-rippee","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPUFVtTFY4S0RMLTllelROc1cxYk51d0pTbFZuX2xpLWlZTVBWZVlNSWp3NEJhWWIwUDFPTmhCeS0zUmJ2MElMYzNWb1IyYVdhRDR3dkZPYnNQbW1xWlUteGtkSmx3U1hyVF84bjBEd29FcXB4bUVFM0IxUjRhc3VuZEkweEZSSXFkaHFEOGlVNmFYNjJxMkdKcjAySHJyd3NvTGc?oc=5","date":"2022-08-18","type":"trial","source":"neurologylive.com","summary":"Phase 2 Trial of OXE103 in Concussion Reports Positive Interim Progress - neurologylive.com","headline":"Phase 2 Trial of OXE103 in Concussion Reports Positive Interim Progress","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}